Medical Articles 7/30

Posted by rob on July 30, 2008 under Uncategorized | Be the First to Comment

A PDE Model for Imatinib-Treated Chronic Myelogenous Leukemia.

A case of coexistence between JAK2V617F and BCR /ABL.
The therapeutic potential of the proteasome in leukaemia.

Lamivudine treatment in a patient with hepatitis B virus reactivation after allogenic peripheral bone marrow transplantation.

Medical Articles 7/25

Posted by rob on July 25, 2008 under Uncategorized | Be the First to Comment

Low bone density and decreased inhibin-B/FSH ratio in a boy treated with imatinib during puberty.

Haematopoietic
cell transplantation with non-myeloablative conditioning in Denmark:
disease-specific outcome, complications and hospitalization
requirements of the first 100 transplants.

Medical Articles 7/18

Posted by rob on July 18, 2008 under Uncategorized | Be the First to Comment

Transformation
by Oncogenic Mutants and Ligand-Dependent Activation of FLT3 Wild-type
Requires the Tyrosine Residues 589 and 591.

The effects of imatinib on pregnancy outcome.

Pre-transplant
depression as risk factor for survival of patients undergoing
allogeneic haematopoietic stem cell transplantation.

Medical Articles 7/16

Posted by rob on July 16, 2008 under Uncategorized | Be the First to Comment

Simultaneous detection of JAK2 V617F mutation and Bcr-Abl translocation in a patient with chronic myelogenous leukemia.

The role of beta-catenin in chronic myeloproliferative disorders.

Medical Articles 7/9

Posted by rob on July 9, 2008 under Uncategorized | Be the First to Comment

Anti-Bcl2 therapy in chronic myelogenous leukemia.

The Jeremiah Metzger Lecture: intelligent design of cancer therapy: trials and tribulations.